{
    "title": "FDA staff says safety issues with Biogen's ALS drug to not prevent approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11881557/US-FDA-staff-flags-no-new-safety-concerns-Biogens-ALS-drug.html",
    "date": "2023-03-20",
    "keywords": [
        "drug",
        "approval",
        "staff",
        "trial",
        "bhanvi",
        "disease",
        "protein",
        "study",
        "health",
        "safety",
        "form",
        "sclerosis",
        "lou",
        "panel",
        "food",
        "administration",
        "wednesday",
        "efficacy",
        "vote",
        "effectiveness",
        "reduction",
        "tofersen",
        "goal",
        "neurofilament",
        "latestage",
        "flexibility",
        "marketing",
        "lifethreatening",
        "cord",
        "inflammation",
        "nerve",
        "population",
        "majority",
        "way",
        "biogen",
        "data",
        "extension",
        "fdas",
        "benefit",
        "company",
        "mutation",
        "gene",
        "dismutase",
        "reporting",
        "raghav",
        "mahobe",
        "satija",
        "bengaluru",
        "editing",
        "krishna",
        "chandra",
        "eluri",
        "shinjini",
        "ganguli"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}